Atara Biotherapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Redmile Group, LLC(9.9%),Jeremy C. Green(9.9%), etc.
Atara Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Nguyen AnhCo
Atara Biotherapeutics | 3: Initial statement of beneficial ownership of securities-Director Adiumentum Capital Fund I LP
Atara Biotherapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Adiumentum Capital Fund I LP(19.99%),Adiumentum Capital Fund I GP LLC(19.99%), etc.
Atara Biotherapeutics | 424B5: Prospectus
Atara Biotherapeutics | 8-K: Current report
Atara Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Touchon Pascal
Atara Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Henrich Jill
Atara Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Hyllengren Eric J
Atara Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Murugan Amar
Atara Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Nguyen AnhCo
Atara Biotherapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Atara Biotherapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Atara Biotherapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Atara Biotherapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Atara Biotherapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Atara Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Touchon Pascal
Atara Biotherapeutics | 10-Q: Q2 2024 Earnings Report
Atara Biotherapeutics | 8-K: Atara Biotherapeutics Announces Second Quarter 2024 Financial Results, Operational Progress and Leadership Update
Atara Biotherapeutics | 8-K: Current report
No Data
No Data